The present invention relates generally to methods of covering and/or coating medical devices and more particularly to methods of manipulating the compliance of the cover to modify fluid mechanics on the interior of the medical device and the friction points on the exterior thereof.
Stents are devices that are inserted into a vessel or passage to keep the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, stents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Vascular as well as not vascular stenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.
Historically, in order to provide a stent with varying characteristics, the stent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stents are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent characteristics along the surface area of the stent. This is particularly undesirable when the stent is to be placed in vascular or nonvascular lumens that have been occluded for one reason or another. The stent needs to be stiffer in some regions while more flexible in others.
Additionally, medical device companies have identified the need to cover stents at least partially to prevent the epithelialization of the scaffolding. Most covered stents however have an elastomeric cover that is subject to bunching particularly about stenotic tissue. This can lead to additional tissue granulation. Additionally, the stents are dip coated which can lead to uneven coating as well as inconsistency in stent performance from batch to batch.
Additionally the ends of the stent tend to be exposed in order to encourage granulation tissue formation, which helps to anchor the stent in place. With metal stents, the direct metal to tissue contact accelerates tissue granulation and galvanic current generation is also an undesirable byproduct. Such direct current can have indirect effects on tissue granulation and direct effects on fluid flow dynamics.
Moreover, since many medical device companies have chosen to use poorly adapted cardiovascular stents for Pulmonary, GI and Peripheral Vascular indications, many of the anatomical differences in the lumens are not accounted for in stent design. For example, the pulsation of the cardiovascular lumen and the concomitant radial force requirements of a cardiovascular stent differ substantially from that of a tightly constricted lumen such as the trachea during repeated coughing. When a stent developed for the former is indicated for the latter, the stent tends to fail under the extreme conditions and lose its elasticity and therefore its ability of ensure airway patency. Non-vascular lumens also tend to have ciliated epithelia so as to facilitate clearance of fluids and particulates. As a general principal, coated stents were not specifically designed for ciliated lumen in that the external coating damages the cilia and prevents the body's natural clearing function. Moreover, the coating itself is usually made of a predominately hydrophilic polymer, which can lead to mucous formation and/or fluid stagnation. Stagnation of fluids or material passing through the lumen can lead to additional complications such as in stent restenosis or bacterial infections.
Therefore, there remains an existing need for a therapeutic stent that can have varying characteristics along its surface area while being stamped, not branded, from a single base material. Moreover, there is a need for such a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations. In particular, there is a need for a stent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for stents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular. An additional need exists for a method of differentially modifying the location, compliance, and density of the cover to achieve desired behavior. In particular, there is a need for a covered stent that is preferably covered internally such that the outer scaffolding surface of the stent is raised from the outer surface of the coating. To this end, cilia function is only partially limited and mucociliary clearance is not significantly affected. A need also remains for a coating that itself has anti-adherent properties or is complexed with an anti-adherent such that bacteria, fungi or other microbials cannot colonize the cover in particular and the stent generally. There also remains a need for a cover for the proximal and distal ends of the stent that prevent epithelialization and granulation tissue formation while achieving the benefits of traditional uncovered stents.
It is a principal purpose of the present invention to provide a stent, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, it is an objective of a preferred embodiment in accordance with the present invention to provide a stent that is easily installed, yet in alternative embodiments, removable. Moreover the stent in accordance with this embodiment of the present invention would not cause material infections and may be capable of reducing infection. Therefore, a principal objective of a preferred embodiment in accordance with the present invention is to provide a prosthesis that is suitable for both permanent and temporary use while being easy to insert, reposition and remove.
A principal objective of a preferred embodiment of the present invention is to provide a stent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the stent does not have a seam that could aggravate luminal tissue. In particular, a stent in accordance with the present invention is formed using a tool that molds the stents outer contour as well as its interstices.
It is yet another objective of an exemplary embodiment of the present invention to provide a stent that can be indicated for the treatment of benign and malignant disease and improve the way clinicians treat malignant obstructions.
Still another objective of the present invention is to provide a stent and method for installing the stent that is economical and suitable for routine purposes. Moreover, the stent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.
Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.
A principal objective of an exemplary stent in accordance with the present invention is to provide a family of stents where the relative hardness/softness of regions of the stent can differ from other regions of the stent to provide additional patient comfort and resistance to radial forces.
An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.
Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent having the above benefits that also defines a plurality of apertures at the termini of the stent or along the scaffolding there between for, inter alia, removal of the stent. In the furtherance of this and other objective, suture may be treaded through one or more of these apertures to facilitate purse string like removal of the device.
An additional objective in accordance with a preferred embodiment of the present invention is to provide a prosthesis that minimizes cilia destruction at the site of implantation. In the furtherance of this and other objectives, the preferred prosthesis is coated internally with a polyurethane such that the surfaces of the struts that come into contact with the lumen of the patient are elevated above the surface of the coating such that the cilia can move to allow for free fluid action of ciliated epithelium.
Still another objective in accordance with the present invention is to provide a cover and method for applying the cover to a stent. The cover may be applied such that the cover is at various levels of compliance with respect to the stent struts. To this end, it provides an opportunity to manipulate flow mechanics for the inner diameter of the stent as well as the friction points of the outer diameter of the stent.
Yet another objective in accordance with the present invention is to provide covering about the distal end, the proximal end or combination so as to retain the benefits of an uncovered stent while retaining the ability to remove the stent. Moreover, the end only and full stent covering may be provided in addition to the coating to eliminate galvanic current.
Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.
A preferred embodiment of the stent, in accordance with the present invention, provides a stent that prevents epithelialization of the stent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location. The stent also retains its axial length while undergoing radial compression.
The stent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof. The composite material is generally formed into a compressed tube from which the stent is etched and is formed on a suitable shaping device to give the stent the desired external geometry. Both the synthetic collar techniques and in vitro valuation techniques show the remarkable ability of stents in accordance with the present invention to convert acting force into deformation work absorbed by the angled structure, which prevents excessive scaffolding stress and premature material fatigue and accelerated obsolescence.
Though one skilled in the stent engineering art, once apprised of the present application, would be able to manufacture a stent consistent with the present invention by other methods, a preferred method of manufacturing such stents follows. As stated above a composite material is selected and a blank is formed there from. The blank is preferably laser etched and the etch work is generally verified for accuracy using visual recording microscopy. Dimensional measurements are taken to ensure strut thickness, segment angles, zone placement, etc. Moreover, the stent is preferably formed on a shaping tool that has substantially the desired contour of the external stent dimensions.
In the event the stent is to be shaped to the dimensions of a particular lumen, optical photography and/or optical videography of the target lumen may be conducted prior to stent formation. The geometry of corresponding zones and connector regions of the stent then can be etched and formed in accordance with the requirements of that target lumen. For example, if the stent were designed for the trachea, which has a substantially D shaped lumen and additionally the middle zones needed to be softer than the end zones, the stent could be designed to those specifications. Stent angles may be modified to provide different characteristics to different zones of the stent. In particular, if the topography of the trachea of a particular patient is captured optically and the appropriate dimension provided, a patient specific prosthesis could be engineered. These techniques can be adapted to other non-vascular lumen but is very well suited for vascular applications where patient specific topography is a function of a variety of factors such as genetics, lifestyle, etc.
It should be pointed out that unlike the use of differing shape memory materials to change regions of a stent, stents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of stent engineering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, additional functionality may be achieved.
Exemplary stents in accordance with the present invention are shown in
The stent also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary stents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.
It cannot be overemphasized, however, that this does not mean the knowledge that changes in the geometry of interstices affect stent functionality is currently known in the art. To the contrary, the present inventors discovered the interrelation between interstice geometry, width, length and relative resistance to torsional stress and radial force. In fact, it can be said that the stent has circumferential bands extending perpendicularly with respect to the luminal device's longitudinal axis. These bands are referred to generally as zones. A connector connects these bands to one another; the connector is an additional means for adjusting stent functionality. In particular, the connector defines a substantially U shaped member, but could define other geometries such as U, V, W, Z, S and X to name a few. Also a plurality of eyelets that allow a physician to purse string the stent with suture to facilitate removability. The eyelets are preferably between about 200 μm and 300 μm, however, the eyelets may be smaller or larger to accommodate the need of the target site. The preferred eyelet size is about 350 μm as the preferred suture type is 4-0. The medical appliance may be pre-threaded with suture or the user may provide the suture after implantation.
An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft. An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 μm in the compressed state (i.e., contracted in the 3 mm tube subject to laser etching). Moreover, the length of the crossing member is preferably about 1.0 μm. The lengths of the leg members are preferably about 1.5 μm long. Additionally the leg members may further comprise feet that attached to the remainder of the stent scaffolding. The feet can be adjusted from a standard length of about 0.25 μm to further adjust the characteristics of the stent. There is additionally a substantially rectangular member incorporated in the U shaped connector with similar capacity for variability. The variability factors and results of modifying the dimensions of the substantially rectangular members are similar to those evinced by leg length dimensional modifications.
By way of example, but not to be construed in any way as limiting, the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U shaped connector, flexibility increases. However, with respect to the distance between U shaped members and distance between interstices in a preferred stent embodiment, there is an inverse correlation between length and softness. This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity. By way of non-limiting example, a U shaped connector with short legs deviating from the crossing member at angles greater than 90°, will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.
In addition to the length and spacing differences, the interstices themselves may define various shapes that by their very nature afford novel functionality to the stent. The changes of functionality, however, are more a function of the dimensional differences of the various shapes rather than a function of the shapes themselves. Therefore, it is important to keep in mind that the dimensional differences discussed in the previous paragraph are determinative of the functionality accorded the stent by the varying interstice geometries. It is for this reason that one of ordinary skill in the art, after being apprised of the present invention, would be able to conceive of a number of interstice geometries to satisfy certain functionality criteria by keeping certain dimensional parameters constant.
Regardless of desired coating surface characteristics, preferred stents in accordance with the present invention are covered from the interior of the stent lumen. In one embodiment, the cover adheres completely to contours of the stent struts. The cover may be strategically applied to either form a strut compliant membrane, a non-compliant membrane within the internal diameter of the stent or incrementally in between. One of the principal functions of the variable covering method is to enhance friction points on the exterior of the stent and/or control flow dynamics through the interior lumen of the stent.
Making specific reference to
With respect to
The stent is preferably coated in a multi-step process, which comprises providing a stent and initially spraying the stent with a polymeric material to coat the struts. Though the steps may be reversed it is preferable to follow the spraying step with the interior coating step. In particular, the stent is placed into a hollow mold to retain the stent shape as the internal diameter of the stent is coated with the polymeric material to form a non-porous cover 200. An alternative cover could be porous for breathability or selective leaching. The cover 100 can be provided in sheets or additional spray applications, however, the preferred embodiment is thin sheets. Sheets are generally preferred to facilitate the proper orientation of the polymer side chains to ensure that the desired moiety (e.g., hydrophilic and/or hydrophobic) is facing the lumen. Once the layer of polymer is introduced into the inner diameter of the stent, an application device such as a balloon or other device in which temperature can be regulated is implanted to sandwich the layer of polymer between the stent inner diameter and the balloon. The balloon is expanded and heated to a temperature of about between 200° and 400° F. to anneal the polymer to the stent. Preferred polymers such as various designer polyurethanes (e.g., Cronoflex® manufactured by Cardiotech International) are suitable for such applications but other polymers are acceptable. Degree of conformity may depend on the compliance of the balloon as well as the presence or absence of a collar about the external surface of the stent. The collar may have ribs complementary to the stent interstices or alternatively recessed wells to facilitate the extent of super compliance of the cover.
Additionally, the same methods may be employed to cover and coat portions of the stent rather than the complete stent. In particular, smaller pieces of covering material may be applied to the distal and proximal ends of the stent to prevent excessive granulation material. Such stents would be valuable in cases such as photodynamic therapy and lung transplants where bare metal stents are generally employed.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.
This patent application is a continuation in part of and claims the benefit of priority under 35 U.S.C. §120 to U.S. Nonprovisional application Ser. No. 10/288,615, filed Nov. 5, 2002 now U.S. Pat. No. 7,527,644, which is incorporated in its entirety by this reference.
Number | Name | Date | Kind |
---|---|---|---|
3818511 | Goldberg et al. | Jun 1974 | A |
4343048 | Ross et al. | Aug 1982 | A |
4441215 | Kaster | Apr 1984 | A |
4655771 | Wallsten | Apr 1987 | A |
4665906 | Jervis | May 1987 | A |
4680031 | Alonso | Jul 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4739762 | Palmaz | Apr 1988 | A |
4743251 | Barra | May 1988 | A |
4800882 | Gianturco | Jan 1989 | A |
4820262 | Finney | Apr 1989 | A |
4820298 | Leveen et al. | Apr 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
5032128 | Alonso | Jul 1991 | A |
5061275 | Wallsten et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5067957 | Jervis | Nov 1991 | A |
5073694 | Tessier et al. | Dec 1991 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5190546 | Jervis | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5229431 | Pinchuk | Jul 1993 | A |
5292331 | Boneau | Mar 1994 | A |
5345057 | Muller | Sep 1994 | A |
5354309 | Schnepp-Pesch et al. | Oct 1994 | A |
5356423 | Tihon et al. | Oct 1994 | A |
5364340 | Coll | Nov 1994 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5383925 | Schmitt | Jan 1995 | A |
5421955 | Lau et al. | Jun 1995 | A |
5433723 | Lindenberg et al. | Jul 1995 | A |
5443498 | Fontaine | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5480431 | Frietag et al. | Jan 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5520697 | Lindenberg et al. | May 1996 | A |
5534287 | Lukic | Jul 1996 | A |
5540713 | Schnepp-Pesch et al. | Jul 1996 | A |
5556414 | Turi | Sep 1996 | A |
5562725 | Schmitt et al. | Oct 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5591157 | Hennings et al. | Jan 1997 | A |
5591197 | Orth et al. | Jan 1997 | A |
5593442 | Klein | Jan 1997 | A |
5597378 | Jervis | Jan 1997 | A |
5601593 | Freitag | Feb 1997 | A |
5609629 | Fearnot et al. | Mar 1997 | A |
5618301 | Hauenstein et al. | Apr 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5662713 | Andersen et al. | Sep 1997 | A |
5667486 | Mikulich et al. | Sep 1997 | A |
5674241 | Bley et al. | Oct 1997 | A |
5681346 | Orth et al. | Oct 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5695499 | Helgrson et al. | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5702418 | Ravenscroft | Dec 1997 | A |
5707386 | Schnepp-Pesch et al. | Jan 1998 | A |
5713949 | Jayaraman | Feb 1998 | A |
5716393 | Lindenberg et al. | Feb 1998 | A |
5725572 | Lam et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5741333 | Frid | Apr 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5759192 | Saunders | Jun 1998 | A |
5766238 | Lau et al. | Jun 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5780807 | Saunders | Jul 1998 | A |
5807404 | Richter | Sep 1998 | A |
5814063 | Freitag | Sep 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5833707 | McIntyre et al. | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5837313 | Ding et al. | Nov 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5853419 | Imran | Dec 1998 | A |
5860999 | Schnepp-Pesch et al. | Jan 1999 | A |
5873904 | Ragheb et al. | Feb 1999 | A |
5876418 | KarlheinzHauenstein et al. | Mar 1999 | A |
5876445 | Andersen et al. | Mar 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5876449 | Starck et al. | Mar 1999 | A |
5879370 | Fischell et al. | Mar 1999 | A |
5902475 | Trozera et al. | May 1999 | A |
5911732 | Hojeibane | Jun 1999 | A |
5922019 | Hankh et al. | Jul 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5922119 | Hankh et al. | Jul 1999 | A |
5922393 | Jayaraman | Jul 1999 | A |
5931866 | Frantzen | Aug 1999 | A |
5935162 | Dang | Aug 1999 | A |
5938682 | Hojeibane et al. | Aug 1999 | A |
5968070 | Bley et al. | Oct 1999 | A |
5968091 | Pinchuk et al. | Oct 1999 | A |
5971950 | Lopez et al. | Oct 1999 | A |
5972018 | Israel et al. | Oct 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
6017365 | Von Oepen | Jan 2000 | A |
6019778 | Wilson et al. | Feb 2000 | A |
6022371 | Killion | Feb 2000 | A |
6027527 | Asano et al. | Feb 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6042597 | Kveen et al. | Mar 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6051021 | Frid | Apr 2000 | A |
6053941 | Lindenberg et al. | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059811 | Pinchasik et al. | May 2000 | A |
6096070 | Ragheb et al. | Aug 2000 | A |
6099560 | Penn et al. | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6131266 | Saunders | Oct 2000 | A |
6132461 | Thompson | Oct 2000 | A |
6136006 | Johnson et al. | Oct 2000 | A |
6136022 | Nunez et al. | Oct 2000 | A |
6139573 | Sogard et al. | Oct 2000 | A |
6146403 | St. Germain | Nov 2000 | A |
6146416 | Andersen et al. | Nov 2000 | A |
6156052 | Richter et al. | Dec 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6171334 | Cox | Jan 2001 | B1 |
6174329 | Callol et al. | Jan 2001 | B1 |
6179867 | Cox | Jan 2001 | B1 |
6183506 | Penn et al. | Feb 2001 | B1 |
6190407 | Ogle et al. | Feb 2001 | B1 |
6193744 | Ehr et al. | Feb 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6206916 | Furst | Mar 2001 | B1 |
6217608 | Penn et al. | Apr 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6231599 | Ley | May 2001 | B1 |
6238430 | Klumb et al. | May 2001 | B1 |
6241760 | Jang | Jun 2001 | B1 |
6248058 | Silverman et al. | Jun 2001 | B1 |
6251134 | Alt et al. | Jun 2001 | B1 |
6258121 | Yang et al. | Jul 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6273910 | Limon | Aug 2001 | B1 |
6283992 | Hankh et al. | Sep 2001 | B1 |
6293964 | Yadav | Sep 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6293968 | Taheri | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312459 | Huang et al. | Nov 2001 | B1 |
6315794 | Richter | Nov 2001 | B1 |
6322586 | Monroe et al. | Nov 2001 | B1 |
6325821 | Gaschino et al. | Dec 2001 | B1 |
6325825 | Kula et al. | Dec 2001 | B1 |
6336938 | Kavteladze et al. | Jan 2002 | B1 |
6348065 | Brown et al. | Feb 2002 | B1 |
6352552 | Levinson et al. | Mar 2002 | B1 |
6355063 | Calcote | Mar 2002 | B1 |
6361557 | Gittings et al. | Mar 2002 | B1 |
6375676 | Cox | Apr 2002 | B1 |
6375677 | Penn et al. | Apr 2002 | B1 |
6380457 | Yurek et al. | Apr 2002 | B1 |
6395020 | Ley et al. | May 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6409754 | Smith et al. | Jun 2002 | B1 |
6416538 | Ley et al. | Jul 2002 | B1 |
6420378 | Rubinfeld | Jul 2002 | B1 |
6423084 | St. Germain | Jul 2002 | B1 |
6423091 | Hojeibane | Jul 2002 | B1 |
6423092 | Datta et al. | Jul 2002 | B2 |
6428570 | Globerman | Aug 2002 | B1 |
6432133 | Lau et al. | Aug 2002 | B1 |
6436133 | Furst et al. | Aug 2002 | B1 |
6440162 | Cox et al. | Aug 2002 | B1 |
6443982 | Israel et al. | Sep 2002 | B1 |
6451049 | Vallana et al. | Sep 2002 | B2 |
6461380 | Cox | Oct 2002 | B1 |
6461381 | Israel et al. | Oct 2002 | B2 |
6464720 | Boatman et al. | Oct 2002 | B2 |
6464722 | Israel et al. | Oct 2002 | B2 |
6471721 | Dang | Oct 2002 | B1 |
6475234 | Richter et al. | Nov 2002 | B1 |
6475236 | Roubin et al. | Nov 2002 | B1 |
6478815 | Alt | Nov 2002 | B1 |
6488703 | Kveen et al. | Dec 2002 | B1 |
6503556 | Harish et al. | Jan 2003 | B2 |
6508834 | Pinchasik et al. | Jan 2003 | B1 |
6514285 | Pinchasik et al. | Feb 2003 | B1 |
6533805 | Jervis | Mar 2003 | B1 |
6533810 | Hankh et al. | Mar 2003 | B2 |
6540776 | Sanders millare et al. | Apr 2003 | B2 |
6540777 | Stenzel | Apr 2003 | B2 |
6551351 | Smith et al. | Apr 2003 | B2 |
6569150 | Teague et al. | May 2003 | B2 |
6569194 | Pelton | May 2003 | B1 |
6572646 | Boylan et al. | Jun 2003 | B1 |
6589276 | Pinchasik et al. | Jul 2003 | B2 |
6602285 | Von Oepen et al. | Aug 2003 | B1 |
6607551 | Sullivan et al. | Aug 2003 | B1 |
6613078 | Barone | Sep 2003 | B1 |
6613079 | Wolinsky et al. | Sep 2003 | B1 |
6613080 | Lootz | Sep 2003 | B1 |
6613081 | Kim et al. | Sep 2003 | B2 |
6616688 | Von Oepen | Sep 2003 | B2 |
6616689 | Ainsworth et al. | Sep 2003 | B1 |
6616690 | Rolando et al. | Sep 2003 | B2 |
6620192 | Jalisi | Sep 2003 | B1 |
6620193 | Lau et al. | Sep 2003 | B1 |
6620201 | Nadal et al. | Sep 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6623520 | Jalisi | Sep 2003 | B2 |
6629994 | Gomez et al. | Oct 2003 | B2 |
6635084 | Israel et al. | Oct 2003 | B2 |
6638293 | Makower et al. | Oct 2003 | B1 |
6638300 | Frantzen | Oct 2003 | B1 |
6638302 | Curcio et al. | Oct 2003 | B1 |
6641607 | Hossainy et al. | Nov 2003 | B1 |
6641608 | Pulnev | Nov 2003 | B1 |
6641609 | Globerman | Nov 2003 | B2 |
6641611 | Jayaraman | Nov 2003 | B2 |
6645240 | Yec | Nov 2003 | B2 |
6645242 | Quinn | Nov 2003 | B1 |
6652572 | Kugler et al. | Nov 2003 | B2 |
6652573 | Von Oepen | Nov 2003 | B2 |
6652575 | Wang | Nov 2003 | B2 |
6652579 | Cox et al. | Nov 2003 | B1 |
6653426 | Alvarado et al. | Nov 2003 | B2 |
6656201 | Ferrera et al. | Dec 2003 | B2 |
6656214 | Fogarty et al. | Dec 2003 | B1 |
6656216 | Hossainy et al. | Dec 2003 | B1 |
6656217 | Herzog, Jr. et al. | Dec 2003 | B1 |
6656220 | Gomez et al. | Dec 2003 | B1 |
6656351 | Boyle | Dec 2003 | B2 |
6660019 | Richter et al. | Dec 2003 | B1 |
6660030 | Shaolian et al. | Dec 2003 | B2 |
6660034 | Mandrusov et al. | Dec 2003 | B1 |
6660827 | Loomis et al. | Dec 2003 | B2 |
6663664 | Pacetti | Dec 2003 | B1 |
6664335 | Krishnan | Dec 2003 | B2 |
6666881 | Richter et al. | Dec 2003 | B1 |
6666884 | Webster | Dec 2003 | B1 |
6669721 | Bose et al. | Dec 2003 | B1 |
6669722 | Chen et al. | Dec 2003 | B2 |
6669723 | Killion et al. | Dec 2003 | B2 |
6673102 | Vonesh et al. | Jan 2004 | B1 |
6673103 | Golds et al. | Jan 2004 | B1 |
6673104 | Barry | Jan 2004 | B2 |
6673105 | Chen | Jan 2004 | B1 |
6673106 | Mitelberg et al. | Jan 2004 | B2 |
6673107 | Brandt et al. | Jan 2004 | B1 |
6673154 | Pacetti et al. | Jan 2004 | B1 |
6676693 | Belding et al. | Jan 2004 | B1 |
6676697 | Richter | Jan 2004 | B1 |
6679910 | Granada | Jan 2004 | B1 |
6679911 | Burgermeister | Jan 2004 | B2 |
6682554 | Oepen et al. | Jan 2004 | B2 |
6685736 | White et al. | Feb 2004 | B1 |
6685745 | Reever | Feb 2004 | B2 |
6689158 | White et al. | Feb 2004 | B1 |
6689162 | Thompson | Feb 2004 | B1 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6692521 | Pinchasik | Feb 2004 | B2 |
6692522 | Richter | Feb 2004 | B1 |
6695833 | Frantzen | Feb 2004 | B1 |
6695876 | Marotta et al. | Feb 2004 | B1 |
6699276 | Sogard et al. | Mar 2004 | B2 |
6699278 | Fischell et al. | Mar 2004 | B2 |
6702849 | Dutta et al. | Mar 2004 | B1 |
6706061 | Fischell et al. | Mar 2004 | B1 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6709440 | Callol et al. | Mar 2004 | B2 |
6709451 | Noble et al. | Mar 2004 | B1 |
6709453 | Pinchasik et al. | Mar 2004 | B2 |
6709454 | Cox et al. | Mar 2004 | B1 |
6712843 | Elliott | Mar 2004 | B2 |
6712844 | Pacetti | Mar 2004 | B2 |
6712846 | Kraus et al. | Mar 2004 | B1 |
6716240 | Fischell et al. | Apr 2004 | B2 |
6719782 | Chuter | Apr 2004 | B1 |
6719991 | Darouiche et al. | Apr 2004 | B2 |
6723118 | Ballou et al. | Apr 2004 | B1 |
6723119 | Pinchasik et al. | Apr 2004 | B2 |
6723120 | Yan | Apr 2004 | B2 |
6723121 | Zhong | Apr 2004 | B1 |
6723373 | Narayanan et al. | Apr 2004 | B1 |
6730064 | Ragheb et al. | May 2004 | B2 |
6730116 | Wolinsky et al. | May 2004 | B1 |
6730117 | Tseng et al. | May 2004 | B1 |
6730120 | Berg et al. | May 2004 | B2 |
6733523 | Shaolian et al. | May 2004 | B2 |
6733524 | Tseng et al. | May 2004 | B2 |
6736838 | Richter | May 2004 | B1 |
6736843 | Fariabi | May 2004 | B1 |
6736844 | Glatt et al. | May 2004 | B1 |
6740113 | Vrba | May 2004 | B2 |
6740114 | Burgermeister | May 2004 | B2 |
6740115 | Lombardi et al. | May 2004 | B2 |
6743219 | Dwyer et al. | Jun 2004 | B1 |
6743252 | Bates et al. | Jun 2004 | B1 |
6746475 | Rivelli, Jr. | Jun 2004 | B1 |
6746476 | Hojeibane | Jun 2004 | B1 |
6746477 | Moore | Jun 2004 | B2 |
6746479 | Ehr et al. | Jun 2004 | B2 |
6746482 | Ung-Chhun | Jun 2004 | B2 |
6749627 | Thompson et al. | Jun 2004 | B2 |
6749629 | Hong et al. | Jun 2004 | B1 |
6752819 | Brady et al. | Jun 2004 | B1 |
6752826 | Holloway et al. | Jun 2004 | B2 |
6752829 | Kocur et al. | Jun 2004 | B2 |
6753071 | Pacetti | Jun 2004 | B1 |
6755856 | Fierens et al. | Jun 2004 | B2 |
6756007 | Pletzer et al. | Jun 2004 | B2 |
6758858 | McCrea et al. | Jul 2004 | B2 |
6758859 | Dang et al. | Jul 2004 | B1 |
6758860 | Penn et al. | Jul 2004 | B1 |
6761731 | Majercak | Jul 2004 | B2 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6764506 | Roubin et al. | Jul 2004 | B2 |
6764507 | Shanley et al. | Jul 2004 | B2 |
6764519 | Whitmore, III | Jul 2004 | B2 |
6770086 | Girton | Aug 2004 | B1 |
6770088 | Jang | Aug 2004 | B1 |
6770089 | Hong et al. | Aug 2004 | B1 |
6770091 | Richter et al. | Aug 2004 | B2 |
6773445 | Finlay et al. | Aug 2004 | B2 |
6773448 | Kusleika et al. | Aug 2004 | B2 |
6774157 | DelMain | Aug 2004 | B2 |
6774278 | Ragheb et al. | Aug 2004 | B1 |
6776022 | Kula et al. | Aug 2004 | B2 |
6776792 | Yan et al. | Aug 2004 | B1 |
6776793 | Brown et al. | Aug 2004 | B2 |
6776794 | Hong et al. | Aug 2004 | B1 |
6776795 | Pelton | Aug 2004 | B2 |
6776796 | Falotico et al. | Aug 2004 | B2 |
6786918 | Krivoruchko et al. | Sep 2004 | B1 |
6786929 | Gambale et al. | Sep 2004 | B2 |
6790222 | Kugler et al. | Sep 2004 | B2 |
6790227 | Burgermeister | Sep 2004 | B2 |
6790228 | Hossainy et al. | Sep 2004 | B2 |
6796997 | Penn et al. | Sep 2004 | B1 |
6797217 | McCrea et al. | Sep 2004 | B2 |
6800089 | Wang | Oct 2004 | B1 |
6802846 | Hauschild et al. | Oct 2004 | B2 |
6802859 | Pazienza et al. | Oct 2004 | B1 |
6805702 | Chen et al. | Oct 2004 | B1 |
6805703 | McMorrow | Oct 2004 | B2 |
6805704 | Hoyns | Oct 2004 | B1 |
6805705 | Hong et al. | Oct 2004 | B2 |
6805706 | Solovay et al. | Oct 2004 | B2 |
6805707 | Hong et al. | Oct 2004 | B1 |
6805709 | Schaldach et al. | Oct 2004 | B1 |
6805898 | Wu et al. | Oct 2004 | B1 |
6808533 | Goodwin et al. | Oct 2004 | B1 |
6814749 | Cox et al. | Nov 2004 | B2 |
6818013 | Mitelberg et al. | Nov 2004 | B2 |
6818014 | Cox et al. | Nov 2004 | B2 |
6818015 | Hankh et al. | Nov 2004 | B2 |
6818247 | Chen et al. | Nov 2004 | B1 |
6821291 | Bolea et al. | Nov 2004 | B2 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6821293 | Pinchasik | Nov 2004 | B2 |
6830638 | Boylan et al. | Dec 2004 | B2 |
6833004 | Ishii et al. | Dec 2004 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6849086 | Cragg | Feb 2005 | B2 |
6852123 | Brown | Feb 2005 | B2 |
6852124 | Cox et al. | Feb 2005 | B2 |
6858037 | Penn et al. | Feb 2005 | B2 |
6860898 | Stack et al. | Mar 2005 | B2 |
6860900 | Clerc et al. | Mar 2005 | B2 |
6863684 | Kim et al. | Mar 2005 | B2 |
6866805 | Hong et al. | Mar 2005 | B2 |
6875227 | Yoon | Apr 2005 | B2 |
6878162 | Bales et al. | Apr 2005 | B2 |
6881221 | Golds | Apr 2005 | B2 |
6881222 | White et al. | Apr 2005 | B2 |
6881223 | Penn et al. | Apr 2005 | B2 |
6887264 | Penn et al. | May 2005 | B2 |
6896696 | Doran et al. | May 2005 | B2 |
6896697 | Yip et al. | May 2005 | B1 |
6896698 | Rolando et al. | May 2005 | B2 |
6899727 | Armstrong et al. | May 2005 | B2 |
6899729 | Cox et al. | May 2005 | B1 |
6908624 | Hossainy et al. | Jun 2005 | B2 |
6911039 | Shiu et al. | Jun 2005 | B2 |
6911041 | Zschecg | Jun 2005 | B1 |
6913617 | Reiss | Jul 2005 | B1 |
6916336 | Patel et al. | Jul 2005 | B2 |
6920677 | Dolan et al. | Jul 2005 | B2 |
6942674 | Belef et al. | Sep 2005 | B2 |
6953475 | Shaolian et al. | Oct 2005 | B2 |
6955723 | Pacetti et al. | Oct 2005 | B2 |
6972054 | Kerrigan | Dec 2005 | B2 |
6979348 | Sundar | Dec 2005 | B2 |
6981985 | Brown et al. | Jan 2006 | B2 |
6984244 | Perez et al. | Jan 2006 | B2 |
6989024 | Herbert et al. | Jan 2006 | B2 |
7004966 | Edwin et al. | Feb 2006 | B2 |
7011675 | Hemerick et al. | Mar 2006 | B2 |
7547321 | Roubin et al. | Jun 2009 | B2 |
20010000043 | Israel et al. | Mar 2001 | A1 |
20010005793 | Brenneman | Jun 2001 | A1 |
20010016767 | Wilson et al. | Aug 2001 | A1 |
20010016768 | Wilson et al. | Aug 2001 | A1 |
20010025195 | Schaolian et al. | Sep 2001 | A1 |
20010027339 | Boatman et al. | Oct 2001 | A1 |
20010037138 | Wilston et al. | Nov 2001 | A1 |
20020002396 | Fulkerson | Jan 2002 | A1 |
20020002399 | Huxel et al. | Jan 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020045933 | Jang | Apr 2002 | A1 |
20020111672 | Kim et al. | Aug 2002 | A1 |
20020156524 | Ehr et al. | Oct 2002 | A1 |
20020178570 | Sogard et al. | Dec 2002 | A1 |
20020183831 | Rolando et al. | Dec 2002 | A1 |
20020183832 | Penn et al. | Dec 2002 | A1 |
20020193866 | Saunders | Dec 2002 | A1 |
20020198593 | Gomez et al. | Dec 2002 | A1 |
20030004567 | Boyle et al. | Jan 2003 | A1 |
20030024534 | Silvestri et al. | Feb 2003 | A1 |
20030028240 | Nolting et al. | Feb 2003 | A1 |
20030036793 | Richter et al. | Feb 2003 | A1 |
20030040803 | Rioux et al. | Feb 2003 | A1 |
20030045925 | Jayaraman | Mar 2003 | A1 |
20030050690 | Kveen et al. | Mar 2003 | A1 |
20030072868 | Harish et al. | Apr 2003 | A1 |
20030074049 | Hoganson et al. | Apr 2003 | A1 |
20030077310 | Pathak et al. | Apr 2003 | A1 |
20030083734 | Friedrich et al. | May 2003 | A1 |
20030105511 | Welsh et al. | Jun 2003 | A1 |
20030105513 | Moriuchi et al. | Jun 2003 | A1 |
20030114919 | McQuiston et al. | Jun 2003 | A1 |
20030125799 | Limon | Jul 2003 | A1 |
20030130611 | Martin | Jul 2003 | A1 |
20030139796 | Sequin et al. | Jul 2003 | A1 |
20030139803 | Sequin et al. | Jul 2003 | A1 |
20030144726 | Majercak et al. | Jul 2003 | A1 |
20030144731 | Wolinsky et al. | Jul 2003 | A1 |
20030149469 | Wolinsky et al. | Aug 2003 | A1 |
20030158596 | Ikeuchi et al. | Aug 2003 | A1 |
20030208183 | Whalen et al. | Nov 2003 | A1 |
20030212450 | Schlick | Nov 2003 | A1 |
20030236567 | Elliot | Dec 2003 | A1 |
20040059406 | Cully et al. | Mar 2004 | A1 |
20040102834 | Nakano et al. | May 2004 | A1 |
20040122511 | Mangiardi et al. | Jun 2004 | A1 |
20040176833 | Pavcnik et al. | Sep 2004 | A1 |
20040230119 | Brustad et al. | Nov 2004 | A1 |
20040256769 | Walter | Dec 2004 | A1 |
20050154448 | Cully et al. | Jul 2005 | A1 |
20050192620 | Cully et al. | Sep 2005 | A1 |
20050261183 | Stewart et al. | Nov 2005 | A1 |
Number | Date | Country |
---|---|---|
2356911 | Jul 2000 | CA |
197 54 747 | Jun 1999 | DE |
199 06 956 A 1 | Aug 2000 | DE |
199 37 638 A 1 | May 2001 | DE |
0 183 372 | Oct 1984 | EP |
0 350 302 | Jan 1990 | EP |
0 378 151 | Jul 1990 | EP |
0 540 290 | May 1993 | EP |
0 621 015 | Oct 1994 | EP |
0 797 963 | Jan 1997 | EP |
0 792 627 | Mar 1997 | EP |
0 945 107 | Jan 1999 | EP |
1036550 | Sep 2000 | EP |
1 093 771 | Apr 2001 | EP |
1088528 | Apr 2001 | EP |
1 208 814 | Sep 2001 | EP |
1151730 | Nov 2001 | EP |
1197188 | Apr 2002 | EP |
1 290 984 | Dec 2003 | EP |
1 472 990 | Nov 2004 | EP |
1550477 | Jul 2005 | EP |
2758253 | Jul 1998 | FR |
2002-102251 | Apr 2002 | JP |
2002-345971 | Dec 2002 | JP |
WO 9113384 | Sep 1991 | WO |
WO 9211824 | Jul 1992 | WO |
WO 9322986 | Nov 1993 | WO |
WO 9404096 | Mar 1994 | WO |
WO 9421196 | Sep 1994 | WO |
WO 9707751 | Mar 1997 | WO |
WO 9710011 | Mar 1997 | WO |
WO 9732543 | Mar 1997 | WO |
WO 9819628 | May 1998 | WO |
WO 9902105 | Jan 1999 | WO |
WO 9940876 | Aug 1999 | WO |
WO 9962430 | Dec 1999 | WO |
WO 0009041 | Feb 2000 | WO |
WO 0044309 | Aug 2000 | WO |
WO 0045742 | Aug 2000 | WO |
WO 0166035 | Sep 2001 | WO |
WO 0172239 | Oct 2001 | WO |
WO 0176508 | Oct 2001 | WO |
WO 0219948 | Mar 2002 | WO |
WO 0224111 | Mar 2002 | WO |
WO 0294132 | Dec 2002 | WO |
WO 02100298 | Dec 2002 | WO |
WO 03007781 | Jan 2003 | WO |
WO 03018083 | Mar 2003 | WO |
WO 03057075 | Jul 2003 | WO |
WO 03065933 | Aug 2003 | WO |
WO 03075797 | Sep 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 2005011527 | Feb 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20040127974 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10288615 | Nov 2002 | US |
Child | 10718217 | US |